jcm-logo

Journal Browser

Journal Browser

Advances in Plastic and Reconstructive and Aesthetic Surgery of Face, Breast and Body

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Plastic, Reconstructive and Aesthetic Surgery/Aesthetic Medicine".

Deadline for manuscript submissions: 31 August 2025 | Viewed by 1140

Special Issue Editor


E-Mail Website
Guest Editor
Department of Plastic Surgery, Vivantes Hospital Friedrichshain, 10249 Berlin, Germany
Interests: reconstructive surgery; microsurgical breast reconstruction; aesthetic surgery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

As the guest editor for this Special Issue of our esteemed journal, we invite contributions that explore the multifaceted landscape of plastic and reconstructive surgery. This issue aims to highlight advancements in reconstructive techniques, with a particular focus on reconstructive and breast surgery, which remain a pivotal area of innovation and clinical practice. We encourage submissions that present novel academic research, including clinical trials, systematic reviews, and meta-analyses that contribute to the evidence base in plastic surgery.

Additionally, we seek to examine the intersection of social media and plastic surgery, an increasingly relevant topic in contemporary practice. Articles that investigate the impact of social media on patient perceptions, decision-making, and the dissemination of information within the field are particularly welcome. We believe that this Special Issue will not only showcase cutting-edge research and innovations but also foster a dialogue on the evolving role of digital platforms in shaping the future of plastic and reconstructive surgery. We look forward to your valuable contributions that will enrich this important discourse.

Dr. Valentin Haug
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • reconstructive surgery
  • academic plastic surgery
  • research
  • social media in plastic surgery
  • breast surgery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

21 pages, 12169 KiB  
Article
“Ozempic Face”: An Emerging Drug-Related Aesthetic Concern and Its Treatment with Endotissutal Bipolar Radiofrequency (RF)—Our Experience
by Luciano Catalfamo, Francesco Saverio De Ponte and Danilo De Rinaldis
J. Clin. Med. 2025, 14(15), 5269; https://doi.org/10.3390/jcm14155269 - 25 Jul 2025
Viewed by 379
Abstract
Background/Objectives: “Ozempic face” is an aesthetic side effect associated with the use of the antidiabetic agent Ozempic (semaglutide), characterized by a prematurely aged and fatigued facial appearance due to rapid weight loss. Currently, treatment options for this condition are limited. In this study, [...] Read more.
Background/Objectives: “Ozempic face” is an aesthetic side effect associated with the use of the antidiabetic agent Ozempic (semaglutide), characterized by a prematurely aged and fatigued facial appearance due to rapid weight loss. Currently, treatment options for this condition are limited. In this study, we present our clinical experience with the BodyTite device, provided by InMode Italy S.r.l. (Rome, Italy). Materials and Methods: We report a case series involving 24 patients (19 women and 5 men, aged 27–65 years), treated with subdermal bipolar radiofrequency (Endotissutal Bipolar Radiofrequency) between 2023 and 2024. All patients underwent a minimum follow-up of 12 months. At the end of the follow-up period, patients rated their satisfaction on a from 0 to 10 scale, and an independent expert assessed the stability of clinical outcomes. Results: The majority of patients reported high satisfaction levels (≥8), which correlated with the independent expert’s evaluation of treatment efficacy and result stability. The only observed adverse event was transient cutaneous erythema. Conclusions: “Ozempic face” is an increasingly common side effect associated with newer classes of antidiabetic medications. Although these drugs offer significant metabolic benefits, the accompanying facial volume loss and aging are often poorly tolerated by patients. Our findings suggest that subdermal bipolar radiofrequency represents a safe, low-risk, and cost-effective therapeutic option for the aesthetic management of Ozempic face. Full article
Show Figures

Figure 1

12 pages, 1234 KiB  
Article
Establishment of Norms for Facial Discriminative Sensitivity in Healthy Women Aged 45–60 Years: A Reference Framework
by François-Régis Sarhan, Thomas Davergne, Christine Couturaud, Sylvie Testelin and Stéphanie Dakpé
J. Clin. Med. 2025, 14(14), 4884; https://doi.org/10.3390/jcm14144884 - 9 Jul 2025
Viewed by 416
Abstract
Background/Objectives: In the context of facial surgery, particularly reconstructive procedures, sensory recovery is a critical yet often underexplored aspect of functional rehabilitation. Sensory-motor recovery can be considered a key marker of integration following reconstructive surgery. Among sensory modalities, discriminative sensitivity is typically the [...] Read more.
Background/Objectives: In the context of facial surgery, particularly reconstructive procedures, sensory recovery is a critical yet often underexplored aspect of functional rehabilitation. Sensory-motor recovery can be considered a key marker of integration following reconstructive surgery. Among sensory modalities, discriminative sensitivity is typically the last to recover, making its evaluation particularly relevant. While established norms for hand sensitivity exist in the literature, there is a paucity of data regarding facial sensitivity. The objective of this study was to evaluate the discriminative sensitivity of the face in a population of healthy women aged 45–60 years. Methods: A total of 20 healthy women were included between January and March 2013. Participants had no history of facial pathologies or trauma. Discriminative sensitivity was measured using the Disk-Criminator™ device across eight facial zones. A detailed mapping of the tested areas was performed. Data obtained were compared with the existing literature. Statistical analyses included Shapiro–Wilk tests for normality, followed by Student’s t-tests for group comparisons. To account for small sample size and verify robustness, non-parametric Mann–Whitney U tests were also performed. Adjustment for multiple comparisons was applied using the Bonferroni correction (adjusted α = 0.0125). Results: The mean age of participants was 52.3 years (±4.0 years). Discrimination threshold values ranged from 2.9 to 14.3 mm. Comparison with existing studies showed no significant age-related differences in zone 2R (cheek) and zone 8 (lower lip), suggesting stable sensitivity in these regions across adulthood. However, a significant decline in sensitivity with age was observed only in zone 1R (forehead), with a p-value < 0.001 after Bonferroni correction. Conclusions: We established a reference framework for cutaneous discriminative sensitivity across eight facial zones. These norms can serve as a baseline for the assessment and monitoring of patients with facial pathologies. Furthermore, our findings contribute to a better understanding of age-related sensory changes. Full article
Show Figures

Figure 1

Back to TopTop